Modern Healthcare Spotlights Success Story in Detroit

In a Q&A piece this week, Modern Healthcare highlights the work of Joe Mullany, CEO of the Detroit Medical Center (DMC), a successful nine-hospital system owned and operated by Tenet Healthcare. The DMC represents one of the more than 1,000 hospital members of the Federation of American Hospitals. In the piece, Mullany discusses the important role the DMC and Tenet have made in improving care and strengthening the communities in and around Detroit, following its acquisition in 2011: -More than half a billion dollars in technology investments -Investments in primary care as part of critical care services -Reducing readmission rates […] Read More »

New Study: Growing Health Insurance Deductibles Putting Greater Burden on Consumers

This week, the Kaiser Family Foundation (KFF) released its annual employer health benefits survey, which highlights an ongoing trend of significant deductible increases that are growing faster than consumer wages and inflation. In a Wall Street Journal blog post, Kaiser Family Foundation President & CEO Drew Altman explains that this year’s survey marks, quote, “a (remarkable) 10-year run of moderate increases, averaging 5%. But the slowdown in health-care cost growth has been all but invisible to average consumers because their out-of-pocket costs have been rising at a time when their wages have been relatively flat…. over the past five years deductibles have […] Read More »

NYT Article Highlights Exorbitant Drug Cost Rise in Health Care

On Monday, the New York Times published an article highlighting the recent, marked price increase of the drug Daraprim. The rapid spike, which saw the drug cost move from $13.50 per tablet to $750 per tablet—a more than 5000% increase in the cost of the drug—is only one example of consistent and extreme drug cost price increases. As the article explains: “Turing’s price increase is not an isolated example. While most of the attention on pharmaceutical prices has been on new drugs for diseases like cancer, hepatitis C and high cholesterol, there is also growing concern about huge price increases on older drugs, some of them […] Read More »